Creative Planning
CRBP icon

Creative Planning’s Corbus Pharmaceuticals CRBP Stock Holding History

Creative Planning’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,707
Closed -$89K – 2179
2021
Q1 		$89K Buy
9,707
+2,874
+42% +$189K ﹤0.01% 2267
2020
Q4 		$46K Buy
6,833
+6,166
+924% +$231K ﹤0.01% 2110
2020
Q3 		$6K Buy
+667
New +$121K ﹤0.01% 2036

Other funds holding CRBP

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Creative Planning's CRBP Position: Q1 2023 in Review

Creative Planning sold out of Corbus Pharmaceuticals (CRBP) in Q1 2023, closing a stake of 6,901 shares — an estimated $22.9K sold.

Creative Planning first reported a position in CRBP in Q3 2015 and held it in 30 quarters. The position peaked at $1.79M in Q2 2020. 30 funds tracked by Wall St. Rank hold CRBP as of Q1 2023.

  • Creative Planning reported no remaining Corbus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Creative Planning sold 6,901 Corbus Pharmaceuticals shares in Q1 2023, an estimated $22.9K.
  • Creative Planning first reported a position in Corbus Pharmaceuticals in Q3 2015 and held it in 30 quarters.
  • Creative Planning's Corbus Pharmaceuticals position peaked at $1.79M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2023.

Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.